Farooq Zubair, Gupta Preeti, Aggarwal Abhinav, Gautam Sachin
Cardiology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, IND.
Cureus. 2024 Oct 31;16(10):e72791. doi: 10.7759/cureus.72791. eCollection 2024 Oct.
Inflammatory cardiac masses are rare and often mimic neoplastic or thrombotic lesions, posing significant diagnostic challenges. These masses are typically identified incidentally during imaging studies, such as echocardiography, and further evaluation with cardiac magnetic resonance imaging (MRI) is required for accurate tissue characterization. Early recognition and appropriate management are crucial to prevent complications. We present the case of a 20-year-old previously healthy female who presented with episodic palpitations lasting seconds to minutes over a two-month period. Transthoracic echocardiography revealed a hyperechoic mass attached to the tricuspid valve, and cardiac MRI indicated inflammatory involvement of the myocardium, with myocardial edema and hyper-trabeculation. Laboratory investigations ruled out infectious etiologies, and she was started on corticosteroid therapy (prednisolone 30 mg daily, tapered over four weeks) along with metoprolol. Despite a reduction in symptoms with treatment, follow-up echocardiography showed persistence of the cardiac mass, raising questions about the efficacy of corticosteroid therapy. During this period, the patient also experienced an episode of ventricular premature contractions (VPCs), detected through smartwatch tracing, although these were not detected on a 24-hour Holter monitor. No significant mass reduction was observed, and her condition remained stable on beta-blocker therapy. This case highlights the diagnostic and therapeutic complexities of inflammatory cardiac masses in young patients. The persistence of the mass despite corticosteroid treatment suggests the potential need for alternative interventions, such as surgical evaluation or biopsy, to confirm the etiology and guide further management. Inflammatory cardiac masses can closely mimic neoplastic growths, necessitating a multidisciplinary approach to optimize outcomes and prevent misdiagnosis. Early detection, accurate diagnosis through advanced imaging, and close follow-up are essential to guide appropriate treatment and prevent complications.
炎症性心脏肿物较为罕见,常酷似肿瘤性或血栓性病变,带来重大诊断挑战。这些肿物通常在超声心动图等影像学检查时偶然发现,需要通过心脏磁共振成像(MRI)进一步评估以准确进行组织特征描述。早期识别和恰当处理对于预防并发症至关重要。我们报告一例20岁既往健康女性,她在两个月内出现持续数秒至数分钟的发作性心悸。经胸超声心动图显示一个高回声肿物附着于三尖瓣,心脏MRI提示心肌有炎症累及,伴有心肌水肿和心肌小梁增粗。实验室检查排除了感染性病因,开始给予皮质类固醇治疗(泼尼松龙每日30mg,四周内逐渐减量)及美托洛尔。尽管治疗后症状有所减轻,但随访超声心动图显示心脏肿物持续存在,这引发了对皮质类固醇治疗疗效的质疑。在此期间,患者还经历了一次室性早搏(VPC)发作,通过智能手表追踪检测到,尽管24小时动态心电图监测未检测到。未观察到肿物明显缩小,她在β受体阻滞剂治疗下病情保持稳定。该病例凸显了年轻患者炎症性心脏肿物的诊断和治疗复杂性。尽管进行了皮质类固醇治疗,肿物仍持续存在,提示可能需要采取替代干预措施,如手术评估或活检,以明确病因并指导进一步治疗。炎症性心脏肿物可酷似肿瘤生长,需要多学科方法以优化治疗效果并防止误诊。早期检测、通过先进影像学进行准确诊断以及密切随访对于指导恰当治疗和预防并发症至关重要。